Total Payments
$1,617
2024 Payments
$948.17
Companies
18
Transactions
72
Medicare Patients
1,094
Medicare Billing
$61,612
Payment Breakdown by Category
Food & Beverage$1,617 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,617 | 72 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $214.68 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $186.81 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $175.05 | 9 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $162.68 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $115.44 | 6 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $110.95 | 5 | $0 (2024) |
| Amgen Inc. | $100.69 | 4 | $0 (2024) |
| GENZYME CORPORATION | $84.96 | 3 | $0 (2024) |
| Incyte Corporation | $76.55 | 3 | $0 (2023) |
| Allergan, Inc. | $75.95 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $948.17 | 48 | ABBVIE INC. ($214.68) |
| 2023 | $322.95 | 16 | Incyte Corporation ($76.55) |
| 2022 | $43.92 | 2 | Allergan, Inc. ($24.40) |
| 2020 | $21.30 | 1 | Allergan, Inc. ($21.30) |
| 2019 | $19.07 | 1 | Allergan Inc. ($19.07) |
| 2018 | $261.93 | 4 | Ortho Dermatologics, a division of Bausch Health US, LLC ($162.68) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.19 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.36 | General |
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $28.58 | General |
| Category: Immunology | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Immunology | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.22 | General |
| Category: Immunology | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.97 | General |
| Category: Immunology | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.00 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.65 | General |
| 10/15/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: DERMATOLOGY | ||||||
| 10/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Immunology | ||||||
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.15 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Immunology | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.42 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 392 | 510 | $52,467 | $18,417 |
| 2022 | 7 | 295 | 446 | $42,518 | $16,904 |
| 2021 | 11 | 395 | 606 | $63,181 | $25,594 |
| 2020 | 1 | 12 | 13 | $2,360 | $697.44 |
Total Patients
1,094
Total Services
1,575
Medicare Billing
$61,612
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 131 | $13,520 | $5,640 | 41.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 60 | 60 | $9,094 | $3,490 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 47 | $7,436 | $2,807 | 37.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 41 | 49 | $6,420 | $1,804 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,627 | $1,223 | 33.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 46 | 48 | $4,832 | $1,142 | 23.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 12 | 16 | $2,737 | $781.05 | 28.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 14 | 14 | $1,709 | $508.76 | 29.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 21 | $1,126 | $482.30 | 42.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 21 | 26 | $1,464 | $419.04 | 28.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 24 | 84 | $502.85 | $120.24 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $11,732 | $4,453 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 70 | $7,152 | $3,602 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 47 | $7,492 | $3,407 | 45.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 41 | 41 | $6,206 | $2,317 | 37.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 48 | 61 | $7,798 | $2,298 | 29.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 21 | $1,067 | $580.45 | 54.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 35 | 160 | $1,070 | $246.43 | 23.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 52 | 74 | $10,662 | $5,661 | 53.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 55 | 55 | $13,074 | $5,396 | 41.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 80 | $7,508 | $3,946 | 52.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 43 | 43 | $6,068 | $2,437 | 40.2% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2021 | 15 | 17 | $7,657 | $2,252 | 29.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 34 | 48 | $5,852 | $1,942 | 33.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 59 | 67 | $6,474 | $1,876 | 29.0% |
About Dr. Ayyaz Shah, DO
Dr. Ayyaz Shah, DO is a Dermatology healthcare provider based in Vestal, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1619167673.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ayyaz Shah, DO has received a total of $1,617 in payments from pharmaceutical and medical device companies, with $948.17 received in 2024. These payments were reported across 72 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,617).
As a Medicare-enrolled provider, Shah has provided services to 1,094 Medicare beneficiaries, totaling 1,575 services with total Medicare billing of $61,612. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Vestal, NY
- Active Since 07/26/2007
- Last Updated 10/27/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1619167673
Products in Payments
- Sotyktu (Drug) $186.81
- TREMFYA (Drug) $175.05
- SKYRIZI (Biological) $123.23
- ILUMYA (Biological) $110.95
- Otezla (Drug) $100.69
- DUPIXENT (Biological) $84.96
- OPZELURA (Drug) $76.55
- ADBRY (Biological) $59.67
- SPEVIGO (Drug) $55.34
- BOTOX COSMETIC (Biological) $51.55
- Bimzelx (Biological) $46.72
- RINVOQ (Biological) $42.16
- TALTZ (Drug) $40.67
- CYLTEZO (Drug) $33.74
- CYLTEZO (Biological) $26.36
- BOTOX (Biological) $24.40
- Cimzia (Drug) $23.55
- HYRIMOZ (Drug) $19.43
- XTRAC (Device) $17.11
- QULIPTA (Drug) $15.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Vestal
Dr. Joseph Newmark, M.d, M.D
Dermatology — Payments: $12,315
Dermatology $12,315
Dr. Colleen Crandell, D.o, D.O
Dermatology — Payments: $5,503
Dermatology $5,503
Romeo Morales, Md, MD
Dermatology — Payments: $3,061
Dermatology $3,061
Shelly Rivas, M.d, M.D
Dermatology — Payments: $1,371
Dermatology $1,371
Dr. Uzoma Oranu, M.d, M.D
Dermatology — Payments: $992.30
Dermatology $992.30
Catalina Dailey, Fnp-C, FNP-C
Dermatology — Payments: $427.62
Dermatology $427.62